Merck Pre-Tax Income 2010-2024 | MRK

Merck pre-tax income for the twelve months ending December 31, 2024 was $19.936B, a 955.37% increase year-over-year.

  • Merck annual pre-tax income for 2024 was $19.936B, a 955.37% increase from 2023.
  • Merck annual pre-tax income for 2023 was $1.889B, a 88.51% decline from 2022.
  • Merck annual pre-tax income for 2022 was $16.444B, a 18.48% increase from 2021.

Merck Pre-Tax Income 2010-2024 | MRK

  • Merck annual pre-tax income for 2024 was $19.936B, a 955.37% increase from 2023.
  • Merck annual pre-tax income for 2023 was $1.889B, a 88.51% decline from 2022.
  • Merck annual pre-tax income for 2022 was $16.444B, a 18.48% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$827.9B
Johnson & Johnson (JNJ)$384.4B
Novo Nordisk (NVO)$375.8B
AbbVie (ABBV)$354.6B
Roche Holding AG (RHHBY)$262.5B
Novartis AG (NVS)$219.3B
Pfizer (PFE)$146.8B
Sanofi (SNY)$137.4B
Bayer (BAYRY)$22.6B
Innoviva (INVA)$1.1B